These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32516359)

  • 1. In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii.
    Seifert H; Müller C; Stefanik D; Higgins PG; Miller A; Kresken M
    J Antimicrob Chemother; 2020 Sep; 75(9):2616-2621. PubMed ID: 32516359
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Karlowsky JA; Hackel MA; McLeod SM; Miller AA
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0078122. PubMed ID: 36005804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant
    Petropoulou D; Siopi M; Vourli S; Pournaras S
    Front Cell Infect Microbiol; 2021; 11():814530. PubMed ID: 35127562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of sulbactam/durlobactam against clinical isolates of Acinetobacter baumannii collected in China.
    Yang Q; Xu Y; Jia P; Zhu Y; Zhang J; Zhang G; Deng J; Hackel M; Bradford PA; Reinhart H
    J Antimicrob Chemother; 2020 Jul; 75(7):1833-1839. PubMed ID: 32306049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of the novel fluorocycline TP-6076 against carbapenem-resistant Acinetobacter baumannii.
    Seifert H; Stefanik D; Olesky M; Higgins PG
    Int J Antimicrob Agents; 2020 Jan; 55(1):105829. PubMed ID: 31669740
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    McLeod SM; Moussa SH; Hackel MA; Miller AA
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988095
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance.
    Findlay J; Poirel L; Bouvier M; Nordmann P
    J Glob Antimicrob Resist; 2022 Sep; 30():445-450. PubMed ID: 35618210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility profile of
    Sharma S; Banerjee T; Yadav G; Kumar A
    Front Cell Infect Microbiol; 2022; 12():1068840. PubMed ID: 36683677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii.
    Seifert H; Stefanik D; Sutcliffe JA; Higgins PG
    Int J Antimicrob Agents; 2018 Jan; 51(1):62-64. PubMed ID: 28705668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK).
    Kaye KS; Shorr AF; Wunderink RG; Du B; Poirier GE; Rana K; Miller A; Lewis D; O'Donnell J; Chen L; Reinhart H; Srinivasan S; Isaacs R; Altarac D
    Lancet Infect Dis; 2023 Sep; 23(9):1072-1084. PubMed ID: 37182534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
    Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ
    J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility.
    Abbey T; Vialichka A; Jurkovic M; Biagi M; Wenzler E
    Microbiol Spectr; 2022 Jun; 10(3):e0054222. PubMed ID: 35647655
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Iovleva A; McElheny CL; Fowler EL; Cober E; Herc ES; Arias CA; Hill C; Baum K; Fowler VG; Chambers HF; Greenwood-Quaintance KE; Patel R; van Duin D; Bonomo RA; Doi Y
    Antimicrob Agents Chemother; 2024 Mar; 68(3):e0125823. PubMed ID: 38289078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H; Kus H; Arslan U; Tuncer I
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii.
    Bian X; Liu X; Feng M; Bergen PJ; Li J; Chen Y; Zheng H; Song S; Zhang J
    Int J Antimicrob Agents; 2021 Feb; 57(2):106271. PubMed ID: 33352235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.
    Wang YC; Kuo SC; Yang YS; Lee YT; Chiu CH; Chuang MF; Lin JC; Chang FY; Chen TL
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4670-6. PubMed ID: 27216052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Singkham-In U; Chatsuwan T
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):169-174. PubMed ID: 29433997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
    Çetinkol Y; Telli M; Altunçekiç Yıldırım A; Çalgın MK
    Mikrobiyol Bul; 2016 Jul; 50(3):460-5. PubMed ID: 27525401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.